Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 409
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01661790 | Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer | ||
| NCT00476996 | A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) | ||
| NCT05918666 | National Register of Actionable Mutations | ||
| NCT00001723 | Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases | ||
| NCT01709097 | Compliance/Adherence After Kidney Transplant, With or With Out Med-O-Wheel™. | ||
| NCT01523340 | A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response | ||
| NCT00476502 | Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r | ||
| NCT02569736 | Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation | ||
| NCT01456312 | HBsAg Related Response Guided Therapy | ||
| NCT02120911 | Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma | ||
| NCT01558167 | A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia | ||
| NCT00626197 | A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) | ||
| NCT04400474 | Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study | ||
| NCT04292574 | UK SMA Patient Registry | ||
| NCT00275665 | The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection. | ||
| NCT00201734 | Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT03784599 | T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC | ||
| NCT00144976 | Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma | ||
| NCT02064491 | Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC | ||
| NCT00217152 | A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors | ||
| NCT01048879 | Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD) | ||
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer | ||
| NCT05038657 | Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). | ||
| NCT06225505 | Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE) | ||
| NCT00275535 | The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients | ||
| NCT01195298 | Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer | ||
| NCT04993274 | Sensitivity of Motor Assessment in MS - a Prospective Cohort Study | ||
| NCT04896710 | COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample | ||
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | ||
| NCT04144270 | The Importance of Muscle Function in Patients With Disseminated Bladder Cancer | ||
| NCT02308527 | Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children | ||
| NCT00562952 | Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients | ||
| NCT03498625 | Crohn's Disease Endoscopic REmission Definition in an Objective Way | ||
| NCT00485589 | A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) | ||
| NCT01633346 | Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients | ||
| NCT05971108 | Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC | ||
| NCT05008081 | The CATALINA Study | ||
| NCT00476164 | Study of Rituximab to Treat Chronic Renal Transplant Rejection | ||
| NCT03654833 | Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma | ||
| NCT01953458 | Therapeutic Option for Hepatitis B and C: a French Cohort | ||
| NCT01220596 | Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. | ||
| NCT00411762 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | ||
| NCT03301493 | Genomic Testing and Resulting Medical Decisions | ||
| NCT00333736 | Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration | ||
| NCT00694408 | A Pilot Trial of Pediatric Liver Transplantation Without Steroids | ||
| NCT00645606 | Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia | ||
| NCT02758665 | Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL | ||
| NCT00353457 | Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma | ||
| NCT01565200 | HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1 |
